Domain Therapeutics Logo
Search on our website
Type Enter to start searching.
Pipeline
Close

 

Program description

Undisclosed GPCR Target

  • Discovery
  • Candidate
  • Preclinical
  • Phase I

Other programs

EP4 receptor antagonist (DT-9081)

Discover

Undisclosed GPCR targets

Discover